JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: TAK-901 (TAK901) is a novel and potent inhibitor of Aurora A/B kinases with potential antitumor activity. It inhibits Aurora A/B with IC50s of 21 nM and 15 nM, respectively, and shows little/no activity against JAK2, c-Src or Abl. TAK-901 displayed potent in vitro antiproliferative activity and high in vivo antitumor efficacy by binding to and inhibiting the activity of Aurora B, leading to a decrease in the proliferation of tumor cells that overexpress Aurora B.
References: Mol Cancer Ther. 2013 Apr; 12(4):460-70.
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!